Introduction
Trichilemmoma was first described in 1962 by Headington and French, in their treatise on the histogenesis and classification of primary neoplasms of the hair follicle, as a benign solid cutaneous epithelial tumor composed of clear cells, with differentiation toward the outer hair root sheath. 1 It is a hamartomatous proliferation arising from glycogen-rich epithelial cells. 2 Trichilemmomas can be solitary or multiple. The single presentation is usually found on the face of adults or the elderly, as a small papule or nodule, similar in color to the underlying skin or slightly erythematous, with a smooth or warty surface. It sometimes exhibits central ulceration as well as keratinization of the epidermal surface, which may be sufficient for the formation of pearls or a cutaneous horn. 3, 4 It may also involve other locations, such as the neck, scalp, thoracic skin or vulva. 2, 3 It presents a slow, progressive growth, and the evolution over time can vary from months to years, with its diameter rarely exceeding 1 cm. 5 The presence of multiple facial trichilemmomas is associated with Cowden syndrome, originally described by Costello in 1940 and named by Lloyd and Dennis in 1963. 6 In 1972, Weary and colleagues described several distinctive mucocutaneous features, such as hamartomatous lesions of ectodermal, mesodermal and ectodermal origin, and proposed the designation "multiple hamartoma syndrome." 7 Later, in 1977, Brownstein and colleagues suggested cutaneous trichilemmomas as a specific marker of this condition. 8, 9 The diagnostic criteria were reviewed at an international consensus meeting that established that the main pathognomonic lesions consist of multiple cutaneous papules, papillomatous alterations of the oral mucosa corresponding to fibromas, as well as palmar or plantar acral keratosis. 10 Histopathologically, trichilemmomas are small and circumscribed lobular or multilobular proliferations, consisting of clear cells from the root of the hair follicle, usually with a large connection to the epidermal surface. 2, 3, 5 The cells' pale appearance is due to the accumulation of glycogen inside them and can be evidenced by periodic acid-Schiff (PAS) staining. 5 A papillomatous surface is common, reflecting the presence of verrucous hyperplasia with hypergranulosis. 5 Peripherally, each lobe also has a small and compact layer of columnar cells arranged in palisade, formed by keratinocytes, usually with a thick adjacent basement membrane. 3, 5 As a sign of their differentiation into the hair follicle's outer root sheath, trichilemmomas express CD34, a feature that has been used to distinguish them from other epithelial tumors through immunohistochemical analysis. [11] [12] [13] In 1990, Hunt and colleagues described a rare histological variant of trichilemmoma that contains areas of narrow irregular cords of epithelial cells trapped in a dense eosinophilic hyaline stroma resembling an invasive carcinoma and called it desmoplastic trichilemmoma. 14 It is predominant in women after the fifth decade of life. 15, 16 Another relevant condition is the trichilemmal carcinoma, initially known as clear cell carcinoma of the skin, which is a malignant neoplasm that combines trichilemmal keratinization with atypical changes such as intense mitotic activity, reticular dermis invasion and ulceration. [17] [18] [19] [20] [21] The differential diagnosis of trichilemmoma includes other epidermal or hair follicle tumors, namely trichofolliculoma, fibroma, inverted follicular keratosis, seborrheic keratosis, intradermal melanocytic nevus and keratoacanthoma. [22] [23] [24] [25] Lesions associated with human papillomavirus such as wart vulgaris or squamous papilloma should also be taken into account. 26 Trichilemmal carcinoma, basal-cell carcinoma and squamous-cell carcinoma are malignant entities that should integrate the differential diagnosis of desmoplastic trichilemmoma. 14, 26 The treatment of trichilemmomas consists of surgical excision, being the recurrence rare, which contributes to a good prognosis. 1, 2, 27 The aim of this paper is to describe a clinical case of a trichilemmoma in the perioral region, addressing the clinical and histological characteristics that allowed its diagnosis, as well as review the treatment suggested in the literature for this pathology, in order to contribute to a greater knowledge of this rare condition.
Case report
A 68-year-old male patient presented with an asymptomatic lesion in his right lip commissure region after referral by his oral hygienist for an oral medicine appointment. No relevant medical history and no smoking or alcoholism were stated. The patient was under treatment with simvastatin to control hypercholesterolemia and pregabalin due to cervical spinal canal stenosis.
At clinical examination, a sessile exophytic cutaneous lesion with papular appearance, 5 mm in diameter with central ulceration was identified. The patient reported a slow growth, with more than 12 months of evolution (Figures 1 and 2) . The clinical characteristics observed were suggestive of benign proliferation, and the lesion was compatible with a keratoacanthoma. The differential diagnosis included intradermal nevus, wart vulgaris and trichilemmoma.
Surgical excision of the lesion was proposed. An excisional biopsy was performed under local anesthesia with 2% lidocaine perilesional infiltration with 1: 80,000 epinephrine (Xilonibsa, INIBSA, Portugal). An elliptical incision was made with scalpel blade 15, followed by suturing of the wound with four single stitches using 5.0-diameter polypropylene monofilament yarn (Hu-Friedy, USA) ( Figure 3 ). Acetaminophen was prescribed for pain relief, and sutures were removed eight days after surgery (Figure 4 ). The surgical specimen was fixed in buffered formalin and sent for anatomopathological examination, which revealed a fully excised trichilemmoma ( Figures  5 and 6) . One year later, the patient's follow-up revealed no recurrence of the lesion (Figure 7) . 
Discussion and conclusions
The cells that originate trichilemmoma appear to be located in a superficial area of the hair follicle, just below the basement membrane, at the level of the sebaceous gland. There is a lobular proliferation of small uniform cells to the dermis from the epidermis, and the presence of clear cells containing glycogen is the most notable alteration. [1] [2] [3] [4] The relationship between trichilemmoma and common wart is controversial, and trichilemmomas are actually often clinically diagnosed as warts. On the other hand, areas histologically similar to trichilemmomas are often found in warts. Some authors, therefore, believe that trichilemmomas may correspond to mere mature warts, with some period of evolution, that have suffered trichilemmal differentiation. 9 However, several studies have failed to detect the human papillomavirus in trichilemmomas. 28, 29 Solitary trichilemmomas should be surgically excised, with a peripheral margin of 2 mm and reaching the fullest depth extent of the tumor. 4, 30, 31 The differential diagnosis of conventional or desmoplastic trichilemmomas should include other benign or malignant tumors of the skin or cutaneous appendages. However, all these entities have distinctive architectural patterns and, unlike trichilemmomas, do not have clear cells or a thick basement membrane. 3 The recognition of the desmoplastic variant, which mimics an invasive carcinoma, is particularly important. 14 Therefore, the correct distinction between desmoplastic trichilemmoma and the various types of carcinoma, namely trichilemmal carcinoma, squamous-cell carcinoma and sclerosing basal-cell carcinoma, is fundamental. The circumscription of the lesion, the identification of chords and small epithelial cell nests fused with a desmoplastic stroma in the central tumor area, the expression of CD34 and the absence of obvious squamous or basaloid differentiation favor the diagnosis of desmoplastic trichilemmoma, excluding the presence of malignancy. 3, 32 Multiple facial trichilemmomas are observed in about 99% of Cowden's syndrome patients, whose transmission is autosomal dominant, despite the incomplete penetrance and variable expression. 33 This multiple hamartoma syndrome results from a mutation in a tumor suppressor gene located on chromosome 10 34 that was simultaneously identified and named by three distinct research groups as PTEN, MMAC1 and TEP1. [35] [36] [37] Patients with this condition are more likely to develop malignant neoplasms, such as breast, thyroid and gastrointestinal cancer. 10, 38, 39 Oral manifestations are one of the main criteria for the diagnosis of this condition and, therefore, oral health professionals should be aware of them. 10 
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